SCHEMBL19686033

SCHEMBL19686033

Cc1ccc2c(c1)C1(c3ccccc3-c3ccccc31)c1cc(C)ccc1N2c1ccc2c(=O)c(C)cn(-c3ccccc3)c2c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
BLM P54132 1/20 0.32
PKM P14618 1/20 0.31
CNR1 P21554 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
MAPK8 P45983 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
NTRK1 P04629 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
POLB P06746 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
SCN2B O60939 1/20 0.30
SCN1A P35498 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19686169 0.92 SCN2B (0.34) PGRKDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL19686035 0.92 MEN1 (0.33) PGRALDH1A1MAPK8MEN1KMT2A
SCHEMBL19685919 0.89 CD74 (0.32) KDM4EALDH1A1HSD17B10CYP1A2HPGD
SCHEMBL19685862 0.88 TP53 (0.35) PGRALDH1A1PKMCNR1GPR55
SCHEMBL19685927 0.85 ESR1 (0.35) PGRKDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL19685984 0.85 ESR1 (0.33) PGRKDM4EALDH1A1HSD17B10CYP1A2
SCHEMBL19685873 0.83 SCN2B (0.36) PGRALDH1A1MEN1KMT2ASCN2B
SCHEMBL19685925 0.83 MAPK8 (0.32) MAPK8SCN2BSCN1ASCN1BSCN5A
SCHEMBL19685823 0.82 MAPK8 (0.33) KDM4EALDH1A1HSD17B10CYP1A2HPGD
SCHEMBL19685817 0.82 TP53 (0.35) PGRKDM4EALDH1A1PKMCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS PGR 607/4885KDM4E 1138/4885ALDH1A1 572/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS PGR 607/4885KDM4E 1138/4885ALDH1A1 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.